Viewing StudyNCT01677390



Ignite Creation Date: 2024-05-06 @ 12:51 AM
Last Modification Date: 2024-10-26 @ 10:56 AM
Study NCT ID: NCT01677390
Status: TERMINATED
Last Update Posted: 2014-01-28
First Post: 2012-08-23

Brief Title: A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
Sponsor: Seagen Inc
Organization: Seagen Inc

Conditions & Keywords Data

Conditions:
Name
Renal Cell Carcinoma
Keywords:
Name View
Drug Therapy View
Antibody-Drug Conjugate View
monomethylauristatin F View
Carcinoma Renal Cell View
Antigens CD70 View